Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
2012
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
2006 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
2012
Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
2016
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Hepatocellular carcinoma
2018 Standout
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy☆
2011
Liver cirrhosis
2014
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening
2011
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
2012
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
2012
Exercise Standards for Testing and Training
2013 Standout
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study
2015
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
2008
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
2013
Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats
2007
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management
2011
Type 2 diabetes
2017 Standout
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Type 1 diabetes
2013 Standout
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
2010
NAFLD, NASH and liver cancer
2013
A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study
2015
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus
2004
Repositioning metformin for cancer prevention and treatment
2013
Third Universal Definition of Myocardial Infarction
2012 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Identification of Specific Ligands for Orphan Olfactory Receptors
2004
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta‐analysis
2008
Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease
2003
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
2013
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
2009
NAFLD: A multisystem disease
2015 Standout
Hepatocellular carcinoma
2022 Standout
Improved Survival in Asymptomatic Diabetic Patients With High-Risk Spect Imaging Treated With Coronary Artery Bypass Grafting
2005
Use of Heart Rate Reserve and Rating of Perceived Exertion to Prescribe Exercise Intensity in Diabetic Autonomic Neuropathy
2003
Exercise and Physical Activity for Older Adults
2009 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Diabetic Neuropathies
2005 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Diabetic Cardiovascular Autonomic Neuropathy
2007
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Feeding Our Immune System: Impact on Metabolism
2008
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus
2009
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial
2016
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Spermidine in health and disease
2018 StandoutScience
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Physical Activity/Exercise and Type 2 Diabetes
2004
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
2010
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Diabetic Somatic Neuropathies
2004 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
2014
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects
2004
Macrophages, Inflammation, and Insulin Resistance
2010 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Emmanuel Cosson being referenced
Comparaison de deux politiques de dépistage du diabète gestationnel : expérience de l'hôpital Jean-Verdier
2006
Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis
2010
Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects?
2005
It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia
2010
Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
2011
Postprandial endothelial dysfunction: role of glucose, lipids and insulin
2006
A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients
2010
Expression of multiple adenylyl cyclase isoforms in human and dog thyroid
2000
Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?
2004
Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes
2006
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
2011
Cardiovascular Risk Prediction Is Improved by Adding Asymptomatic Coronary Status to Routine Risk Assessment in Type 2 Diabetic Patients
2011
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
2012
P289 Résultats métaboliques obtenus à 2 ans sous pompe à insuline ambulatoire chez des diabétiques de type 2 en échec d’insulinothérapie optimisée
2012
Predictive Value of Silent Myocardial Ischemia for Cardiac Events in Diabetic Patients
2005
Predictive Value of Cardiac Autonomic Neuropathy in Diabetic Patients With or Without Silent Myocardial Ischemia
2001